CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE; CALCIPOTRIEN) — FDA Approval ANDA212367 (PADAGIS ISRAEL
CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE; CALCIPOTRIEN) — FDA Approval ANDA212367 (PADAGIS ISRAEL is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE; Active ingredients: BETAMETHASONE DIPROPIONATE; CALCIPO
| Brand name | CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE |
|---|---|
| Active ingredients | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE |
| Application number | ANDA212367 |
| Sponsor | PADAGIS ISRAEL |
| Dosage form | SUSPENSION |
| Route | TOPICAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20200911 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →